We are live on ! Find out more

2,015 hedge funds and large institutions have $111B invested in Abbott in 2019 Q2 according to their latest regulatory filings, with 109 funds opening new positions, 743 increasing their positions, 859 reducing their positions, and 72 closing their positions.

New
Increased
Maintained
Reduced
Closed

51% more first-time investments, than exits

New positions opened: 109 | Existing positions closed: 72

29% more call options, than puts

Call options by funds: $646M | Put options by funds: $503M

6% more capital invested

Capital invested by funds: $105B → $111B (+$6.07B)

2% more funds holding in top 10

Funds holding in top 10: 141144 (+3)

1% more funds holding

Funds holding: 2,0032,015 (+12)

0.19% more ownership

Funds ownership: 74.98%75.17% (+0.19%)

14% less repeat investments, than reductions

Existing positions increased: 743 | Existing positions reduced: 859

Holders
2,015
Holders Change
+12
Holders Change %
+0.6%
% of All Funds
43.76%
Holding in Top 10
144
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+2.13%
% of All Funds
3.13%
New
109
Increased
743
Reduced
859
Closed
72
Calls
$646M
Puts
$503M
Net Calls
+$143M
Net Calls Change
-$55M

ABT Hedge Fund Activity: Q2 2019 in Review

2,015 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Abbott (ABT) for Q2 2019, worth a combined $111B — up 5.8% from $105B a quarter earlier.

Buyers outnumbered sellers: 109 funds opened new ABT positions and 72 closed out — a net gain of 37 holders — while 743 added to existing stakes and 859 trimmed.

The largest buyer was Capital International Investors, adding an estimated $1.07B. The largest seller was T. Rowe Price Associates, cutting an estimated $230M.

  • 2,015 institutional investors held Abbott (ABT) as of Q2 2019, up from 2,003 in Q1 2019.
  • Funds reported $111B of Abbott stock for Q2 2019, up 5.8% quarter-over-quarter.
  • 109 funds opened new Abbott positions in Q2 2019 and 72 closed out, a net change of +37 holders.
  • The largest Abbott buyer in Q2 2019 was Capital International Investors, an estimated $1.07B added.
  • The largest Abbott seller in Q2 2019 was T. Rowe Price Associates, an estimated $230M sold.

Based on aggregated 13F filings for Q2 2019.